# Efficacy Assessment of Systematic Treatment With Folinic Acid and Thyroid Hormone on Psychomotor Development of Down Syndrome Young Children

> **NCT01576705** · PHASE3 · COMPLETED · sponsor: **Institut Jerome Lejeune** · enrollment: 175 (actual)

## Conditions studied

- Down Syndrome

## Interventions

- **DRUG:** thyroid hormone and folinic acid

## Key facts

- **NCT ID:** NCT01576705
- **Lead sponsor:** Institut Jerome Lejeune
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-04-02
- **Primary completion:** 2017-12-14
- **Final completion:** 2017-12-14
- **Target enrollment:** 175 (ACTUAL)
- **Last updated:** 2020-05-13

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01576705

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01576705, "Efficacy Assessment of Systematic Treatment With Folinic Acid and Thyroid Hormone on Psychomotor Development of Down Syndrome Young Children". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01576705. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*